GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shine-On BioMedical Co Ltd (ROCO:6926) » Definitions » Gross-Profit-to-Asset %

Shine-On BioMedical Co (ROCO:6926) Gross-Profit-to-Asset % : 0.00% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shine-On BioMedical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Shine-On BioMedical Co's annualized Gross Profit for the quarter that ended in Jun. 2024 was NT$0.00 Mil. Shine-On BioMedical Co's average Total Assets over the quarter that ended in Jun. 2024 was NT$1,135.74 Mil. Therefore, Shine-On BioMedical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 0.00%.

Shine-On BioMedical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Shine-On BioMedical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shine-On BioMedical Co Gross-Profit-to-Asset % Chart

Shine-On BioMedical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
- - - - 0.57

Shine-On BioMedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross-Profit-to-Asset % Get a 7-Day Free Trial - - - 1.15 -

Competitive Comparison of Shine-On BioMedical Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Shine-On BioMedical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shine-On BioMedical Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shine-On BioMedical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Shine-On BioMedical Co's Gross-Profit-to-Asset % falls into.


Shine-On BioMedical Co Gross-Profit-to-Asset % Calculation

Shine-On BioMedical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=6.667/( (1177.768+1159.715)/ 2 )
=6.667/1168.7415
=0.57 %

Shine-On BioMedical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=0/( (1159.715+1111.758)/ 2 )
=0/1135.7365
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Shine-On BioMedical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Shine-On BioMedical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shine-On BioMedical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shine-On BioMedical Co Ltd (ROCO:6926) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
ROCO:4169 ROCO:6676 ROCO:7808 ROCO:6634 ROCO:4911 ROCO:8279 ROCO:6986 ROCO:7754 TPE:1733 ROCO:6461 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
No. 633, Section 2, Taiwan Avenue, Unit 6, 5th Floor, Xitun District, Taichung, TWN
Website
https://www.shineon-bio.com
Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with the most effective cancer treatment options.

Shine-On BioMedical Co Headlines

No Headlines